C-PALSY Archives

Cerebral Palsy List

C-PALSY@LISTSERV.ICORS.ORG

Options: Use Forum View

Use Monospaced Font
Show Text Part by Default
Show All Mail Headers

Message: [<< First] [< Prev] [Next >] [Last >>]
Topic: [<< First] [< Prev] [Next >] [Last >>]
Author: [<< First] [< Prev] [Next >] [Last >>]

Print Reply
Subject:
From:
Reply To:
St. John's University Cerebral Palsy List
Date:
Fri, 18 Feb 2005 18:39:32 EST
Content-Type:
text/plain
Parts/Attachments:
text/plain (22 lines)
Thought you might like to read this.

Medwatch about Phenergan

Thought some of you might find this useful info:


FDA and Wyeth notified healthcare professionals of revisions to the
CONTRAINDICATIONS, WARNINGS/Use in Pediatric Patients, and DOSAGE AND
ADMINISTRATION sections of the prescribing information for Phenergan.
Phenergan is contraindicated for use in pediatric patients less than two
years of age because of the potential for fatal respiratory depression.
Postmarketing cases of respiratory depression including fatalities, have
been reported with use of Phenergan in pediatric patients less than two
years of age. Caution should also be exercised when administering
Phenerganto pediatric patients two years of age and older.

Read the complete MedWatch 2005 Safety Summary, with links to the Dear
Healthcare Professional letter and revised label, at:

www.fda.gov/medwatch/SAFETY/2005/safety05.htm#phenergan

ATOM RSS1 RSS2